Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's
Marketing
Analysts tip Lilly's Alzheimer's launch to boost rival Leqembi
Analysts are tipping the approval of a rival therapy to boost Leqembi by raising awareness, although they also see risks to the early front-runner.
Nick Paul Taylor
Jun 12, 2024 9:29am
Lilly tipped to beat Eisai, Biogen, win $13B Alzheimer's fight
Jun 7, 2024 4:51am
Biogen plots 30% Leqembi field force bump, omnichannel campaigns
Apr 25, 2024 6:58am
Eisai's Leqembi launch tripped up on a host of challenges
Feb 27, 2024 9:20am
Amid stagnant sales, Biogen touts progress on new launches
Nov 8, 2023 11:29am
A look at FDA's Aduhelm approval and regulatory bias
Oct 27, 2023 8:00am
